- Patent Title: 2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carboxylic acid [(S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide for use in the treatment of pain associated to osteoarthritis
-
Application No.: US15322949Application Date: 2015-06-30
-
Publication No.: US09968605B2Publication Date: 2018-05-15
- Inventor: Tobias Paehler , Klaus Flechsenhar , Kirsten Grothe , Martin Lunnon , Christelle Jan
- Applicant: SANOFI
- Applicant Address: FR Paris
- Assignee: Sanofi
- Current Assignee: Sanofi
- Current Assignee Address: FR Paris
- Agency: McDonnell Boehnen Hulbert & Berghoff
- Priority: EP14306088 20140703
- International Application: PCT/EP2015/064794 WO 20150630
- International Announcement: WO2016/001197 WO 20160107
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07D403/14 ; C07D403/12
![2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carboxylic acid [(S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide for use in the treatment of pain associated to osteoarthritis](/abs-image/US/2018/05/15/US09968605B2/abs.jpg.150x150.jpg)
Abstract:
2-(2-methylamino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid [(S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide for use in the treatment of pain associated with osteoarthritis in the knee.
Public/Granted literature
Information query
IPC分类: